Quick Beauty Tips On The Go

It's hard to admit but planning and preparing for travel can be a little stressful. On top of that, looking good while traveling also causes us a great deal of stress. This may be a little daunting, but there are easy ways that can help xou achieve the same results as having to spend all your time prepping in front of the mirror.

QUICK BEAUTY TIPS ON THE GO

1. Moisturize!

Traveling can wreak havoc on your skin and cause it to get dry. This is especially true when you are flying on a plane. Always pack a lot of moisturizer and apply it on your face. Use one that goes well with your skin type.

2. Blotting Papers

If you feel that your face has gone a little shiny, always pack some blotting paper inside your purse. These are essential for quick touch ups. Who would want to look greasy when they suddenly meet a really cute guy?

3. Lip Stains

If you find it a bit drying to use long lasting lipsticks, a lip stain is your best bet. Before leaving, apply a dab of your favorite lip stain. Allow the color to seep into your lips for a little bit and then apply clear gloss on top of it. You will have fresh looking lips all day. Make sure that you have already exfoliated your lips beforehand, so that your lips will be smooth for application.

4. Minimize Puffy Eyes

If you are in for a really long trip, a great way to minimize puffy eyes is to use a cold compress. You can also use a fresh towel and place some ice cubes inside. Wrap it up and place it on your eyes for a couple of minutes. You will instantly feel refreshed. A cold compress helps in removing puffy eyes by contracting dilated vessels.

5. Skip the Mascara

Leave your lashes bare when you are traveling. The long hours of travel can make your eyes tired. You wouldn't want to have raccoon eyes when you step out of a plane or any form of transportation. Instead, leave your face make up free (or at least apply some tinted moisturizer and a bit of gloss). If you are not used to show your tired eyes, wear big sunglasses. They always come in handy.

You don't have to look oh-so distressed when you are traveling. These wonderful tips will keep you looking fresh and clean no matter where you may go.

Reena Mariel, author of Beauty Is My Duty, your online resource for beauty tips and tricks for the average girl.
Share:

Runaway Growth


Forty years into the "War on Cancer," casualties are mounting -- and we still don't know what motivates the enemy.


Please STOP the Race for the Cure and START the Race for the Cause


The Experimental Generation
In June 2010, a dermatologist cut a weird growth from my left wrist. The growth was wart-sized, grape-purple and stippled black. It was sensitive to the touch and bled when scratched.
Two weeks later, the doctor told me the tumor was malignant -- melanoma, the deadliest form of skin cancer.
The doctor also told me this:
You're part of an experimental generation.
She meant that in the past 30 years, she'd seen an alarming rise in skin cancer, and not just among older people. (I was 45.) Despite the advent of sunscreen and the fact that people don't go outside as much as they used to, she'd even been seeing more moles -- possible precursors to melanoma -- on children. 
One or more risk factors for melanoma, she reasoned, must have changed. My doctor's guess: the human-caused depletion of atmospheric ozone, which allows more ultraviolet light -- a leading melanoma risk factor -- to reach our skins.
But other variables have also changed in recent decades, including the chemicals we're exposed to through air, water and food. How much might exposure to these be increasing the risk for melanoma and other forms of cancer?
Mostly, the answer is: We really don't know. 
And that's the experiment, in which we've become the test subjects -- without our knowledge or consent. 

Less Death, More Cancer
My doctor's language, inevitably, recalled Rachel Carson's Silent Spring. Writing in the years when America first went whole-hog for synthetic chemicals, Carson warned that we were subjecting humanity and nature to a vast, uncontrolled experiment.
In 1964, Carson herself died of cancer. And in a decade that saw rising cancer rates and death tolls, fear of the malady metastasized. On Dec. 23, 1971, President Nixon signed the National Cancer Act, pledging to make the "conquest of cancer a national crusade."
In the next several weeks, you'll likely see 40th-anniversary reports and pronouncements on how this epic initiative -- inevitably dubbed the "War on Cancer" -- is going. Most will gauge progress toward keeping cancer patients alive, or toward the "cancer cure" that Nixon sought. You'll likely hear disappointment that cancer remains uncured, countered with hopeful tidings of new gene-based therapies.
But here's a fact you probably won't hear much: You're actually more likely to get cancer than when the War on Cancer began.
In announcing his "conquest," Nixon noted that cancer struck one in four Americans. Four decades later -- and after hundreds of billions of dollars in research, radiation and chemotherapy -- the figure has risen to about two in five. Nearly half of all men, and more than a third of all women, will get cancer. That's about 1.6 million new diagnoses each year.
And for most major types of cancer, according to National Cancer Institute statistics, incidence remains higher than it was in the early '70s. While record-keeping in the early 1900s was less authoritative, cancer registries suggest incidence also rose steeply for most of the past century; by one estimate, it rose 85 percent between 1950 and 2001 alone.
Meanwhile, between 2003 and 2007, the incidence of liver cancer rose for men, along with thyroid cancer among women. Melanoma climbed for both genders; so did non-Hodgkin lymphoma, leukemia and cancers of the kidney and pancreas.
The news isn't all bad: Incidence of two major types of cancer, colorectal and cervical, have dropped steeply in recent decades, largely because of improved screening. And cancer now kills less surely. Death rates for the most common forms -- lung, breast, colorectal, prostate -- have fallen in the past 20 years.
Even so, 570,000 Americans die of cancer annually -- and the overall cancer death rate is only about 6 percent lower than it was in 1950. Our boat is still leaking; we're just bailing faster.
This trend of "less death" and "more cancer" is starkest among children. Forty years ago, a child with cancer faced a virtual death sentence. (I had a sister who died of neuroblastoma, in 1971, at age 5.) Today, most child cancer victims survive, and death rates keep dropping. But incidence keeps rising -- by about 0.6 percent annually over the past 20 years, mostly driven by leukemia. An estimated 7 million American kids under age 10 are now living with cancer.
Nor is there any easy explanation for dramatic rises in cancers that strike primarily young adults, like testicular cancer. While cancer incidence is dropping in people over age 65, probably because of smoking's long decline, it's rising in people under 50 … despite smoking's long decline.

Our Chemical Romance
Cancer itself is complicated; it's really more than 100 diseases, affecting numerous parts of the body and presenting a wide range of medical challenges. But broadly, cancer happens when cells in our body grow out of control.
Human bodies make cancer cells constantly, and as far as we know, they always have. (Clinical descriptions of cancer seemingly date to ancient Egypt.) Usually, our bodies kill them off. When such cells do thrive, the causes of the disease are sometimes readily identifiable: Lung cancer is largely attributable to smoking; a small number of cancers are caused by viruses (with liver cancer, for instance, linked to hepatitis B and C). Diet and sedentary lifestyles have been implicated in some cancer. Genetics play a role, though likely much less than most people think.
Meanwhile, ever since surgeon Percival Pott observed in 18th-century London that chimney sweeps were prone to cancers of the scrotum, we've also known that many environmental pollutants are carcinogens. Asbestos (still used in automobile brake pads) is one. So is benzene, a common pollutant in automobile and factory exhaust. Likewise formaldehyde, found in consumer products including some wooden furniture and recently designated a "known human carcinogen."
Industrial workers still often bear the brunt of the most severe exposures. The threat is also elevated for inhabitants of areas like Louisiana's "Cancer Alley," a stretch of the Mississippi River known for massive toxic releases from the petrochemical industry, and for exceptionally high cancer rates among its mostly poor, mostly black residents.
Yet the increase in cancer rates isn't confined to specific regions or occupations. Increasingly, researchers are interrogating the environment as a cause of cancer -- and suggesting that cleaning up the environment may help prevent it.
After all, the past century's rise in cancer has been paralleled by the rise in synthetic chemicals and other pollutants in everyday life. In the years following World War II, plastics took over for wood, metal and glass. And from 1950 through 1975, pesticide production -- Rachel Carson's key concern in Silent Spring -- grew sevenfold, to 1.4 billion pounds a year.
In 2008, according to an EPA inventory, there were some 84,000 synthetic chemicals on the market. (There are surely more today.) Most are made from coal, oil or natural gas. But only a handful of these substances have ever been tested for health effects. We're in contact with many of them on a daily basis. They're in diesel soot and they're in shampoo. They reach us through the packaging that contains our food, the pesticides on apples and the flame-retardant fabric woven into children's car seats.
Some of these chemicals accumulate in our bodies. Others are shed into the environment, where they may persist for decades. 
A growing array of studies, for example, link cancers including breast, prostate, leukemia and multiple myeloma to pesticide exposure. I was personally intrigued that a 2007 study from Italy tied melanoma to household pesticide use.
Perhaps the most surprising survey was Reducing Environmental Cancer Risk: What We Can Do Now. The April 2010 report was issued by the President's Cancer Panel, chaired by two appointees of President George W. Bush. The widely publicized report cited "a growing body of evidence linking environmental exposures to cancer." 

Wrong War, Wrong Race
Cancer patients, understandably, care less about why there's cancer than how to treat theirs. And as cancer victims go, I'm lucky; I quickly learned that mine hadn't spread. My only keepsakes so far are a couple of scars (including one for the lymphectomy). 
I'm glad for that, and glad that there are ways to help people sicker than me. But in this four-part series, I'm less interested in the War on Cancer everyone will be talking about. It feels like the War on Terror, or the War on Drugs: a hugely expensive effort to fix a problem whose causes we're ignoring.
What I want to know is, why are we getting sick? Why has melanoma incidence tripled since the 1970s? Why is thyroid cancer rising even faster? Why are men younger than me increasingly getting tumors in their testes? Why are babies getting more cancer? 
And in a country where you can't swing a surgically excised lymph node without hitting someone's Race for the Cure, why does no one ever hold a Race for the Cause?




Share:

Soft-Pedaling Cancer Prevention

We celebrate those who beat cancer ... but ignore efforts to prevent it
By Bill O'Driscoll
News cycle: Stories about Lance Armstrong's recovery ignored the fast-rising incidence of testicular cancer.
In October 1996, Lance Armstrong, then 25 and the world's seventh-ranked professional bicyclist, learned he had testicular cancer. The cancer had spread to his lungs, brain and abdomen. He was given a 40 percent chance of survival. 
"I intend to beat this disease," he told reporters.
Armstrong survived, of course -- the brain surgery, the grueling rounds of chemotherapy -- and went on to seven straight Tour de France titles.
Armstrong's recovery was received joyously. Headlines like "With Each Day, a Triumph" were standard; thousands of fan letters and emails arrived weekly. In 1999, Armstrong told Bicycling magazine, "The cancer -- I owe my life to it. … I wouldn't be married. I wouldn't have a kid on the way. And I'm a [better] rider."
News accounts noted everything from testicular cancer's predilection for young men to survival tips from psychologists. But readers were rarely, if ever, informed that testicular cancer was becoming increasingly common. In the 20 years preceding Armstrong's diagnosis, its incidence in the U.S. had risen by 41 percent. And it has kept rising: By 2007, testicular cancer was 75 percent more common than in 1975. And no one knows why.
Armstrong himself seemed disinterested in what causes testicular cancer. While his Lance Armstrong Foundation, created in 1997, has distributed countless yellow "Livestrong" wristbands, like most cancer initiatives it's all about supporting cancer sufferers, not pursuing root causes.
Or, as Armstrong said shortly after his diagnosis: "I don't want to waste my time saying, ‘Why me?' I have a problem and I want to fix it."

Spinning the Wheels
It's hard to believe we'd need to argue that preventing illness is preferable to trying to cure it. It's as if we'd abandoned sewage-treatment systems because we have antibiotics for cholera.
And curing cancer is proving much harder than developing antibiotics.
Forty years into America's "war on cancer," you're 50 percent more likely to get cancer than when it began. Childhood cancer rates have grown steadily for decades, according to National Cancer Institute statistics, and cancer is rising in people under 50. Yet the Institute's own funding patterns emphasizes new treatments over prevention. 
For instance, in 2010, the National Cancer Institute spent $364 million on prevention programs -- and $1.16 billion on treatment research. (Asked about research priorities, an NCI spokesperson said "grants are awarded on a competitive basis" and research categories "[don't] fully capture the complete range of research objectives" because some research applies in multiple categories.)
Treatment is likewise the focus of the vast majority of funds raised by your average "race for the cure" fundraiser.
Treatment funding has done some good: Childhood cancer and testicular cancer, for example -- both virtual death sentences as recently as the 1970s -- are now mostly treatable. And the rate at which Americans die from cancer has declined from its early-1990s peak.
However, mortality remains just 6 percent lower than in 1950. And providing cancer care is expensive. Spending on treatment has quadrupled in the past three decades. Last year, it reached $125 billion -- 5 percent of the national medical bill.
While that spending is driven largely by the aging population, caring for younger sufferers like Lance Armstrong is pricier because treatment is usually more aggressive. Science magazine recently cited the case of a young father with stomach cancer: His four months of end-of-life treatment cost $350,000.
Moreover, treating cancer is hard -- both on patients and on researchers, who've spent decades searching for a cure. Cancer cells don't mutate just once; they keep mutating, and can develop resistance to drugs.
So why not put more effort into prevention?
It's not a new question. 
In his controversial 1979 book The Politics of Cancer, Samuel Epstein, a professor of environmental medicine, asserted that "cancer is caused mainly by exposure to chemicals or physical agents in the environment." If those chemicals were removed, he argued, cancer would be "essentially preventable." But he charged mainstream experts with downplaying the role of industrial carcinogens -- and with pursuing lucrative treatments for cancer at the expense of prevention. Epstein cited ties between what he called "the cancer establishment" and the petrochemical and pharmaceutical industries; in the 1980s, for instance, the NCI Executive Cancer Panel was chaired by oil magnate Armand Hammer.
Epstein's attacks were roundly criticized by the medical establishment. But little has changed, says epidemiologist Devra Davis, author of The Secret History of the War on Cancer.
"The National Institutes of Health," she quips, "really should be called the National Institutes of Disease."

Why Don't We Know More?
Popular culture too prefers "beating" cancer to sussing its source: For every movie about what carcinogens do, like Erin Brockovich, there are 10 Brian's Songs or 50/50s, celebrating cancer's noble victims or plucky survivors.
Public officials follow suit. When President Richard Nixon was pushing the National Cancer Act, in 1971, he issued a 1,300-word statement. While it briefly acknowledged evidence that "human cancers can be prevented by avoiding exposure to certain chemicals," just 100 words of the statement concerned prevention. (Seven years after the surgeon general's announcement that cigarettes cause cancer, Nixon's statement didn't even mention smoking.) Nixon's repeated references to a "cancer cure," meanwhile, signaled the chief goal.
Critics say those priorities are no accident. As difficult as curing cancer might be, it could be harder to reduce the malignant growth of special interests.
More scientists are now, like Epstein, raising alarms that synthetic chemicals drive cancer. Consider testicular cancer. Studies have linked exposure to hormone-mimicking chemicals (like those found in some pesticides and plastics) to reproductive abnormalities including undescended testicles, a cancer risk factor. Meanwhile, a 2008 study suggested that a byproduct of the pesticide DDT (still found in most Americans' bloodstreams) increases the risk of testicular cancer.
And DDT is just one of at least 84,000 synthetic chemicals. Some are known carcinogens; the vast majority remain untested for health effects.
But passing laws to reduce exposure to such chemicals is difficult, partly because of the chemical industry's political influence. According to opensecrets.org, the industry employs nearly 500 federal lobbyists and regularly spends $50 million a year on lobbying; top spenders this year include Dow Chemical, the American Chemistry Council and DuPont Co. 
Epidemiologist Davis says she and other researchers who confront industry face threats to their funding or careers. Her Secret History of the War on Cancer documents the derailing of several researchers who explored tobacco or industrial pollutants. She cites, for instance, Wilhelm Hueper, whose pioneering research into industrial carcinogens got him fired by DuPont; he later worked for the National Cancer Institute, where industry pressure hamstrung his efforts until he left, in 1968.
When concerns about chemicals do arise, Davis observes, business interests take a page from the tobacco industry: They tout bought-and-paid-for studies showing their products are safe, and question the science behind the alarm bells. 
Consider BPA, a plastics additive that's caused cancer and reproductive problems in lab animals. For years, industry fought state-level bans on BPA in products like baby bottles and sippy cups; in 2009, the American Chemistry Council said that California's effort would "needlessly restrict consumer products deemed to be safe by scientific experts worldwide." In fact, there was some scientific concern about BPA, and a sign-off by the U.S. Food and Drug Administration was later revealed to have been heavily influenced by industry input. Then, just this past October, the ACC announced that manufacturers had quietly removed BPA from such products. "[T]hese products are not on the market. There is no need for parents or consumers to worry about them," said an ACC spokesman.
Davis now runs the Washington, D.C.-based Environmental Health Trust. "Our motto is ‘Making Prevention the Cure,'" she says. "No matter how much money we spend on finding and treating cancer, no matter how good we get at treating it … if we don't reduce the demand, we'll never win."
In the meantime, mystery chemicals continue to proliferate, at a clip not even Lance Armstrong could outrace.

Next week: The Toxins We Live In
Share:

Health or Something Else?

Courtesy ANH-UK
Read a very interesting and related article -

A New York spider gave me an insight into US private healthcare

Occupy Wall Street is right – a rash of bites showed me how private healthcare keeps Americans cowed and compliant


http://www.guardian.co.uk/commentisfree/2011/dec/04/new-york-spider-us-private-healthcare
Share:

Statins appear to harm about as many people as they help


When I was at medical school I remember being lectured on the wonders of hormone replacement therapy (HRT). I was distinctly taught, and without reservation, that women taking HRT had a lower risk of heart disease compared to women ‘going without’. This ‘fact’ turned out to be complete rubbish. Subsequent evidence revealed that HRT actually has the capacity to increase risk of heart disease.
How could we have got it so wrong?
The initial ‘evidence’ on HRT was epidemiological in nature, which meant that it looked at the relationship between HRT/non-HRT use in a population and risk of cardiovascular disease. One fundamental potential problem with these studies relates to what is known as the ‘healthy user’ effect. In short, what this means is that healthier individuals are more likely to be prescribed a drug than sicker people who may already be on multiple medications and prone to side-effects and interactions. So, any ‘benefit’ seen to be associated with a drug may have nothing to do with the drug, and everything to do with the fact that people taking it are inherently healthier.
To untangle all of this, what we need is randomised controlled trials. These trials give essentially equivalent groups the treatment or placebo to assess any potential benefits or harms of the treatment. It’s when these studies were done that we realised that HRT actually increased the risk of heart disease.
The healthy-user effect, though, has not gone away, and is still alive and well in medical research. Here’s another apparent example that concerns cholesterol-reducing drugs known as statins…
In the past, statins have said to help prevent pneumonia (infection in the lung) on the basis of epidemiological studies. However, it is generally the case that frail, elderly individuals, with perhaps complicated health histories are less likely to be prescribed or take statins than healthier individuals. Because of this, when we see lower incidence of infection in those taking statins, we have no idea if it’s the statins, or the fact that these people are generally healthier, or both, that accounts for the reduced infection risk.
One way to get clarity here is to attempt to take into account health status of individuals when performing this sort of analysis. That’s exactly what a team of doctors based in the US did when analysing the relationship between statin use and risk of pneumonia in a study published in 2009 [1]. This more careful analysis revealed that statin use was actually associated with a 26 per cent increased risk of pneumonia. For pneumonia severe enough to require hospitalisation, statin use was associated with a 61 per cent increased risk.
Now, we should not forget that these studies are epidemiological in nature, and cannot be used to prove that statins cause enhanced susceptibility to pneumonia. However, the evidence as it stands is incriminating nonetheless. Further suspicion is raised in the form of evidence which shows that statins have the ability to directly impair the immune system and its ability to resist bacteria [2].
The most comprehensive account of statin side-effects I can find was published last year in the British Medical Journal [3]. Known side-effects of statins include muscle weakness and/or pain (myopathy), liver damage , kidney failure and cataracts. Here, in summary, are the findings of this review:
For every 10,000 women at high risk of CVD [cardiovascular disease] treated with statins, we would expect approximately 271 fewer cases of cardiovascular disease, 8 fewer cases of oesophageal cancer, 23 extra patients with kidney failure, 307 extra patients with cataracts; 74 extra patients with liver dysfunction; and 39 extra patients with myopathy.
For every 10,000 men at high risk of CVD treated with statins, we would expect approximately 301 fewer cases of cardiovascular disease, 9 fewer cases of oesophageal cancer, 29 extra patients with kidney failure, 191 extra patients with cataracts; 71 extra patients with liver dysfunction; and 110 extra patients with myopathy.
This study focused specifically on data relating to individuals deemed to be at high risk of cardiovascular disease. Many individuals who take statins are actually not at high risk of cardiovascular disease. For these, benefits are likely to be significantly lower than those elucidated in this study (while risks are likely to be about the same).
But look at those figures for a moment. Two things jump out to me:
Of 10,000 high-risk individuals, only about 300 will benefit – that’s 3 per cent. That means, of course, 97 per cent will not benefit. The number of people who benefit is roughly matched by those who will get a serious adverse effect. Hands up who wants to take a statin now?
References:1. Dublin S, et al. Statin use and risk of community acquired pneumonia in older people: population based case-control study. BMJ 2009;338:b2137
2. Benati D, et al. Opposite effects of simvastatin on the bactericidal and inflammatory response of macrophages to opsonized S. aureus. J Leukoc Biol. 2010;87(3):433-42
3. Hippisley-Cox J, et al. Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database BMJ 2010;340:c2197
by Dr. John Briffa
Statins appear to harm about as many people as they help
Share:

Thinking About PSA and the Latest News


I live where it is a good 90 minute drive to any city of real size.  When I moved to this area almost ten years ago I was trying to teach the communities about the fact that the PSA test was ineffective.  Of course the closed minds so common in small towns ruled and no one would even try to listen.  Now we know that even the medical profession has decided that PSA can be a real issue leading to over treatment to many who do not even need it.

One forward thinking doctor told me years ago that the acid fast bacteria lab test was much more effective in screening for real cancer cases in men when it came to prostate care.

Like the story my long time colleague tells below, I lost a friend to this dis-ease because of a doctor who always said he would use natural care but it took too much time to tell his patients.

What cost health?




PSA test DOA
by David Christopher, M.H.


You have probably read the news about prostate screening for cancer, which appeared on the front page of many newspapers across the country. On Thursday October 13, 2011 an Associated Press article by Marilynn Marchione basically blasted PSA tests. It related that this test is only a measure of inflammation which can be elevated for many reasons including bike riding, recent sex, or normal enlargement of the prostate due to age. She also debunks the claims that the screening saves lives. She makes these claims by drawing from a very large, well done American study, that\ showed that annual screening did not lower the chances of dying from prostate cancer. Many men believe the screening saved their lives because their urologist erroneously told them it did. These men and urologists become very vocal in promoting prostate cancer screening.


Less visible are the unfortunate men who test high for PSA and are then subjected to invasive testing that can harm or spread cancer. One such case as reported in the article is, "... Donald Weaver who was a healthy 74 year old Kansas farmer until doctors went looking for prostate cancer. A PSA test led to a biopsy and surgery, then a heart attack, organ failure and a coma. His grief stricken wife took him off life support. 'He died of unnecessary preventive medicine,' said his nephew, Dr. Jay Siwek, vice chairman of family medicine at Georgetown University. Blood tests can kill you ..."


The United States Preventive Task Force does not recommend the use of this test, and doctors have been warned by the AMA to leave slow-growing prostate cancer alone; that interference may spread the cancer.


What should we do to prevent prostate cancer? Well first, grow up and eat like an adult. Stop eating those sugary breakfast cereals. Stop drinking milk, it contains hormones that stimulate growth of prostate tissue. The hormones found in meat can also negatively effect prostate health. Do eat plenty of fresh fruits and vegetables, sprouted grains and legumes, and include nuts and seeds in your diet. This program is preventive for not just prostate cancer, but all cancers. If prevention is too late, then do the extended herbal cleanse as explained in the Dr. Christopher Three Day Cleanse booklet.


Next eat the seeds highest in cancer preventing nitrilosides; which are apricot seeds. They are extremely bitter, but buck up and eat six seeds a day to start and work up to as many as 30 per day. These simple seeds are natures' chemo therapy.


Cyanide and benzaldehyde are the chemicals in the seed that destroy cancer cells. These two chemicals are bound to two glucose molecules and are inert until activated at the actual cancer site. This is accomplished enzymatically. The chemicals are released with beta-glucosidase which is found at cancer sites. Healthy cells are surrounded by the enzyme rhodanese, which in the presence of sulfur, converts the cyanide into thiocyanate, which then converts to cyanocobalamin (vitamin B12). The Benzaldehyde, in the presence of oxygen is converted to benzoic acid, an analgesic.


In conclusion, I ask "Why would anyone want to go through risky medical procedures to look for possible prostate cancer, when nature provides a safe and natural chemotherapy, specific to cancer cells and at the same time is nutritive to healthy cells?"


NOTICE: All information in this newsletter is given out as information only and is not intended to diagnose or prescribe. For our official Disclaimer, Biological Individuality, Important Notice-Terms of Use please see: http://www.herballegacy.com/Disclaimer.html


Selections from Natural Health News



Oct 12, 2011
Specifically in regards to prostate cancer, new research published in the International Journal of Cancer has shown that gamma-tocotrienol, a cofactor found in natural vitamin E preparations, actually kills prostate ...



Feb 08, 2009
The prostate-specific antigen (PSA) test measures an enzyme produced almost exclusively by the glandular cells of the prostate. It is secreted during ejaculation into the prostatic ducts that empty into the urethra. PSA liquefies ...
Dec 10, 2009
For this study, Gerhauser's team started with hormone-dependent prostate cancer cells and stimulated them with testosterone, which led to a massive secretion of prostate specific antigen (PSA). "When we treated the cells ...
Dec 16, 2008
On the contrary, high levels of 2-hydroxy estrogens—or “good estrogens” as they're sometimes called—have quite the opposite effect, serving to lower telltale PSA levels and protect vulnerable tissue in the prostate, cervix, ...
Oct 23, 2009
Mammography and prostate-specific antigen (PSA) testing, although having "some effect," have led to the well-documented overdiagnosis and overtreatment of breast and prostate cancers, they note. ...
Share:

Fukushima Update: Japanese Facing Severe Personal Health Problems

The one and continuing underlying factor in this mega disaster, and the two featured stories, has to be the woefully inadequate, if not criminally complicit performance of the Japanese Government.

What should be noted in the report from Fairewinds Associates, is that the data published was as a result of samples collected and submitted by ordinary citizens.

Arnie Gunderson: The data in Mr. Kaltofen's paper came from citizens. It came from farmers. It came from scientists. It came from bloggers. It was an effort by individuals and not government. I think if we had relied on the government to get us this information, we never would have gotten it. So it is an important achievement for all of us, to recognize that together, using the internet, we can all provide information for scientists to use, to come to rational decisions on public policy.



Staying with government and seemingly its willingness to accept whatever it is told by the nuclear industry, this from the second article, Women Fight to Save Fukushima's Children.

The announcement followed approvals from the government given on the basis that the company had taken sufficient measures after the reactor automatically shut down on Oct. 4, due to procedural errors in repair work.

And I have to make mention, this is the same government that has allocated twenty seven million dollars extra, to assist the Japanese whaling fleet in its endeavour to slaughter whales this coming season in the South Atlantic. 4 min video


The meat from which, they can't sell because nobody wants the wretched stuff. The only reason for this is that the Japanese government doesn't want to loose face by conceding defeat to Sea Shepherd Conservation Society.

One might have thought the government had more urgent priorities, starting with doing everything imaginable to safeguard the most vulnerable, the next generation, today's children.
Link

Scientist Marco Kaltofen Presents Data Confirming Hot Particles from Fairewinds Associates on Vimeo.

Washington, DC - October 31, 2011 – Today Scientist Marco Kaltofen of Worcester Polytechnic Institute (WPI) presented his analysis of radioactive isotopic releases from the Fukushima accidents at the annual meeting of the American Public Health Association (APHA). Mr. Kaltofen’s analysis confirms the detection of hot particles in the US and the extensive airborne and ground contamination in northern Japan due to the four nuclear power plant accidents at TEPCO’s Fukushima reactors. Fairewinds believes that this is a personal health issue in Japan and a public health issue in the United States and Canada.

Transcript:

Hi, I'm Arnie Gundersen from Fairewinds.

It is October 31st, 2011. This is a video that contains scientific information that we have been wanting to share with you for a long time. Today, in Washington D.C. at 8:30 in the morning, scientist Marco Kaltofen gave a presentation to some doctors who are part of the American Public Health Association. The paper is now on our website, next to this video.

To summarize the paper, citizens, some doctors and scientists, some bloggers, some farmers, around the world provided samples to Mr. Kaltofen who analyzed them for Fukushima radiation. An example of what he found is a slide that contains air filters from cars in Japan and in the United States. Cars in the United States hardly have any radiation in their air filters. Cars in Tokyo had quite a lot, way too much. Cars in Fukushima Prefecture were incredibly radioactive.

Now I think it is important because the nuclear industry will say, well everything is radioactive and therefore we should not worry. Well, the Seattle data shows that not everything is radioactive. And it shows that the people in Japan received enormous exposures of particles into their lungs and into their digestive systems, during the course of the accident.

Another piece of information is that Fairewinds viewers were able to send in children's shoes from Japan. Mr. Kaltofen has data that clearly show that the concentration of cesium on the kid's shoelaces was astronomically high, around 80 disintegrations per second. What does that mean? Kids tie their shoes, their hands get radioactive and it goes into their G.I. tract. If it is on the ground, it is in the dust in the playground and it is in their lungs. I think that between the two, the air filters and the children's shoes, it shows that there is a severe personal health problem in Japan that will manifest itself in cancers over the next 10 or 20 years.

Now Mr. Kaltofen did not just look at Japan. He set up monitoring stations in the United States as well. Two of the three monitoring stations in the United States did show hot particles in the air in April. Since then, there have not been any hot particles. But in April, it is clear that, at the worst of the accident, hot particles were wafted across the Pacific and deposited in Seattle and in Boston at least. There is also data that indicates contamination on the ground in the Cascades, which are a mountain range right up against the Pacific Ocean.

So I think we have two problems here. In Japan, there is a personal health issue and what that means is that individuals have received enough radiation that there is going to be a statistically meaningful increase in cancers in Tokyo and especially in Fukushima Prefecture.

In the United States, it is a different story. It is a public health issue and not a personal health issue. What that means is that we will never know who is the individual who got cancer from Fukushima. But we can be sure that the radiation did reach here and that there will be an increase in cancers, especially on the West Coast where the Rocky Mountains stopped most of the radiation and deposited it on the ground.

So, this paper was given to the American Public Health Association. And here it is a public health issue. We cannot run and we cannot hide. But the radiation is up and down the West Coast and then also scattered about the rest of the United States.

In Japan, it is a different story. They need to aggressively go after the contamination that has been discovered. It is so obvious on these air filters and on children's shoes. It takes a concerted national effort, not a haphazard effort of chasing hot spots, in order to reduce the amount of radioactivity that is on the soil and in the air in Japan right now.

And the last thing the paper shows is that it is wrong to have a 10 mile evacuation planning zone. Clearly, the damage can extend out as far as Tokyo. We need to look at emergency planning and evacuations well beyond the 10 miles that the Nuclear Regulatory Commission uses here and the 12 miles that the Japanese used during the accident. You may recall that the Nuclear Regulatory Commission said that Americans needed to evacuate 50 miles from Fukushima at the peak of the accident. Well, if it is good enough for Americans living in Japan, that same criteria should be good enough for Americans living in the United States.

The data in Mr. Kaltofen's paper came from citizens. It came from farmers. It came from scientists. It came from bloggers. It was an effort by individuals and not government. I think if we had relied on the government to get us this information, we never would have gotten it. So it is an important achievement for all of us, to recognize that together, using the internet, we can all provide information for scientists to use, to come to rational decisions on public policy.

This November we are asking for your support so we can continue our scientific analysis and these educational videos. There is a donate button on the Fairewinds site and we would appreciate it if you considered a financial contribution.

Thank you very much. We will keep you informed. Fairewinds

- - -

Women Fight to Save Fukushima's Children
By Suvendrini Kakuchi
06 November 2011

Tokyo - Hundreds of Japanese women have been converging on the Japanese capital demanding better relief for some 30,000 children exposed to nuclear radiation by the Fukushima meltdown.

"Official recovery policy focuses on decontamination rather than protecting the health of those most vulnerable - children and pregnant women," activist Aileen Mioko Smith told IPS.

"Our meetings with officials to force faster evacuation programmes for high-risk groups are only met with promises to clear radioactive waste. This is totally irresponsible," said Smith, who leads the non-government organisation (NGO) Green Action Japan.

Smith criticised the government and the Tokyo Electric Power Company (TEPCO), operator of the crippled Fukushima nuclear plant, for focusing energies on defusing public tension by promising to reduce exposure in affected areas to below one millisieverts (a measure of radiation) per year.

On Wednesday, TEPCO admitted that one of the Fukushima reactors showed presence of radioactive material from a burst of nuclear fission, indicating fresh leakage.

After the meltdown - caused by an earthquake and tsunami on Mar. 11 - the acceptable radiation standard for Fukushima residents was lowered to 20 millisieverts per year, and activists like Smith allege that this was done to minimise the number of evacuees.

Smith said the new standards should, in any case, not have been applied to vulnerable sections such as children and pregnant women.

Some 36,000 people have been evacuated from a 22-km radius of the plant while many more of Fukushima’s two million people may be affected, Smith said.

"We will not give up till the government changes its callous attitude," vowed Smith, participant in a women’s sit-in and protest before the ministry of economic trade and industry that determines Japan’s nuclear policy.

The core of the protestors was made of about 200 women from Fukushima who sat on a three-day sit-in outside the Tokyo office of Japan’s ministry of economy. When that ended on Oct. 30, they appealed to women from all over Japan to join them for week-long protests until Sunday.

Women from 47 prefectures have collected more than 6,000 signatures to support their demands. They have been handing out fliers to passers-by that contain detailed information on the dangers faced by the residents of Fukushima.

Rika Mashiko, an evacuee from Fukushima, explained that she joined the protests along with her seven-year-old daughter to show solidarity and to express her disappointment with the government. Her husband continues working in Fukushima to maintain financial stability.

Mashiko left her organic farm in Miharumachi, 50 km from the damaged nuclear reactor, six months ago. She resides in Tama, a Tokyo suburb and works part-time to support herself and her daughter.

"I receive no financial support from the government because officially I left voluntarily - though I am a nuclear refugee. I do not trust the newly established standards for radioactive exposure in Fukushima and cannot risk the health of my young child," she told IPS..

The women have linked post-disaster recovery with achieving stronger protection measures against radiation, transparency and honesty from government officials. They are pushing for a national pledge to end nuclear power generation in Japan.

Ayako Ooga, a representative of the NGO ‘Fukushima Mothers Against Radiation,’ said the success of the government’s recovery programme is under test.

"The way they are going about dealing with the nuclear crisis is not the recovery we envisage," she said. "The policy is to placate the people, but what we want is honest facts from the government."

Ooga fled on Mar. 11 from her home that fell within 10 km of the accident site. She explained to IPS that the high levels of radiation being reported from her area made it impossible for her to return.

"We want an assurance that a similar accident will never happen again in Japan and that the government will do more to protect our friends and relatives from radiation," she said.

The women know they have a long battle ahead. A rude shock came on Nov. 1 when the Kyushu Electric Power Company announced that it would restart a faulty reactor at the Genkai nuclear power station in Saga prefecture, southwestern Japan.

The announcement followed approvals from the government given on the basis that the company had taken sufficient measures after the reactor automatically shut down on Oct. 4, due to procedural errors in repair work.

The plant is at the heart of a scandal following allegations that the utility had manipulated public opinion and pressurised employees to approve restart of the plant.

Hatsumi Ishimaru, a farmer from Genkai who headed a campaign against the restarting of the plant, is among those who have came to Tokyo to join the women's protest.

Ishimaru, who is party to a lawsuit filed by the locals against the Genkai plant, told IPS that she will not rest until her farming village of 3,000 people is rid of the nuclear power generator.

"Women are, today, at the forefront of the anti-nuclear campaign. We value life more than economic returns," she said. ipsnews
Share: